Sai Life Sciences IPO is a Public Cum Offer for Sale (Book Building) issue of Rs 3,042.62 crores. The issue is a fresh issue of 5.54 crore shares.
Read More| Open Date | 11 Dec, 2024 |
| Close Date | 13 Dec, 2024 |
| Lot Size | 27 |
| Minimum Investment | ₹14,823.00 |
| Issue Price | ₹ 522 - ₹ 549 |
| Listing Date | 18 Dec, 2024 |
| Listing On | BSE, NSE |
| Issue Size | ₹ 3,042.62 Cr |
| Face Value | ₹ 1 |
| Total Shares Offered | 55,421,124 |
| Offered To Public | 19,397,393 |
| Retail Max (Shares/Amount) | 351/₹192,699 |
| Pre Issue Promoters Holding | - |
| Sector | Healthcare |
| Sub Sector | Pharmaceuticals & Drugs |
| Issue Type | Public Cum Offer for Sale (Book Building) |
| Category | Subscription Times |
|---|---|
| Qualified Institutional Buyers | 30.93x |
| Retail Individual Investor | 1.37x |
| Non-Instituional Investor | 4.92x |
| Others | 0x |
| Total | 10.26x |
| Date | QIB | RII | NII | Total |
|---|---|---|---|---|
Day 111-12-2024 | 2.62x | 0.18x | 0.15x | 0.84x |
Day 212-12-2024 | 3.32x | 0.42x | 0.59x | 1.25x |
Day 313-12-2024 | 30.93x | 1.37x | 4.92x | 10.26x |
| Investor Category | Shares Offered |
|---|---|
| Anchor Investors | 1,66,26,337 (30.00%) |
| Non-Instituional Investor | 83,13,169 (15.00%) |
| Qualified Institutional Buyers | 1,10,84,225 (20.00%) |
| Retail Individual Investor | 1,93,97,393 (35.00%) |
| Total Shares Offered | 5,54,21,124 (100.00%) |

Company Name | Listing Date | Issue Price | Total Subscription | Listing Open (₹) | Listing Close (₹) | Listing Gain | LTP (₹) | As of Todays Gain | Issue Size | |
|---|---|---|---|---|---|---|---|---|---|---|
Capillary Technologies India IPO | Mainline | 21 Nov 25 | ₹ 577 | 52.95x | - | - | - | ₹ 606.50 | - | 877.50 Cr |
Fujiyama Power Systems IPO | Mainline | 20 Nov 25 | ₹ 228 | 2.14x | 220 | 208.44 | -3.51% | ₹ 208.84 | -5.07% | 828.00 Cr |
Tenneco Clean Air India IPO | Mainline | 19 Nov 25 | ₹ 397 | 58.83x | 505 | 490.8 | 27.20% | ₹ 475.85 | -5.77% | 3,600.00 Cr |
Emmvee Photovoltaic Power IPO | Mainline | 18 Nov 25 | ₹ 217 | 0.97x | 217 | 219.4 | 0.00% | ₹ 232.81 | 7.29% | 2,900.00 Cr |
Mahamaya Lifesciences IPO | SME | 18 Nov 25 | ₹ 114 | 1.59x | - | - | - | ₹ 114.00 | - | 70.44 Cr |